Prostate Cancer Clinical Trials Consortium
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Prostate Cancer Clinical Trials Consortium sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).
Prostate Cancer Clinical Trials Consortium: 4 sponsored US clinical trials, 3 recruiting.
Prostate Cancer Clinical Trials Consortium sponsors 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.
Upper-quartile sponsor footprint
Prostate Cancer Clinical Trials Consortium sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
NCT06844383
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
NCT04995198
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT03151629
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
NCT02685267
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Prostate Cancer Clinical Trials Consortium pipeline
3 recruiting of 4 indexed (75% open).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.